返回
Supreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech
裁决文书日期2023年5月25日签发机构Supreme People’s Court of the People’s Republic of China权限级别终审程序类型司法(民事)文本类型竞争, 专利(发明)原告/上诉人Yangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd; Yangtze River Pharmaceutical Group Co., Ltd.被告/被上诉人Hefei Industrial Pharmaceutical Institute Co., Ltd; Hefei Enrite Pharmaceutical Co., Ltd.关键字
Patent,
Abuse of dominant market position,
Restricting dealing,
Unfairly high price
裁判文书/决定英语Supreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech HTML摘要英语Supreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech HTMLWIPO Lex序号WIPOLEX016-j